Evidence map›Paper›PMID 32635653›Full record

ArticleBiomolecules2020

Albendazole-Schisandrin B Co-Therapy on

Ho Yin Pekkle Lam, Ting-Ruei Liang, Shinn-Jong Jiang, Shih-Yi Peng

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. AnIranian journal of pharmaceutical research : IJPR · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ho Yin Pekkle LamInstitute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan.
Ting-Ruei LiangDepartment of Biochemistry, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
Shinn-Jong JiangDepartment of Biochemistry, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan.
Shih-Yi PengInstitute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan.
Tzu Chi University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A

Indexed as

AlbendazoleAngiostrongylus cantonensisAnimalsApoptosisCyclooctanesDisease Models, AnimalDrug SynergismGene Expression RegulationInflammasomesLignansMeningoencephalitisMiceMice, Inbred BALB CPolycyclic CompoundsPyroptosisStrongylida InfectionsAlbendazoleCyclooctanesInflammasomesLignansPolycyclic Compoundsschizandrin BalbendazoleAngiostrongylusanthelmintic drugcombination therapymeningoencephalitisSchisandrin B

Identifiers

PMID32635653
PMCPMC7407957
OpenAlexW3039008279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.